Kevin Reyes
Overview
Explore the profile of Kevin Reyes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
591
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vasudevan H, Lazar A, Reyes K, Rong D, Arevalo S, Federman S, et al.
Anticancer Res
. 2024 Dec;
44(12):5445-5453.
PMID: 39626922
Background/aim: Plasma Epstein-Barr virus (EBV) viral load measurement is prognostic in nasopharyngeal carcinoma (NPC) disease monitoring; however, a consensus measurement approach does not exist. This study characterized the clinical performance...
2.
Lasa J, Smolarczuk A, Navar S, Ponce C, Galvarini M, Orellana D, et al.
Gastroenterol Hepatol
. 2023 Jun;
47(3):253-261.
PMID: 37330213
Background: The frequency and patterns of use of scores for the assessment of endoscopic activity in inflammatory bowel disease patients are not known. Aim: To describe the prevalence of adequate...
3.
Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, et al.
Clin Genitourin Cancer
. 2023 Jun;
21(5):e394-e404.
PMID: 37316414
Introduction: Urothelial carcinoma with squamous differentiation (UCS) is associated with increased resistance to chemotherapy, but outcomes associated with newer therapies approved in this space over the last 5 to 10...
4.
Fasching C, Servellita V, McKay B, Nagesh V, Broughton J, Sotomayor-Gonzalez A, et al.
J Clin Microbiol
. 2022 Jun;
60(7):e0026122.
PMID: 35766492
Laboratory tests for the accurate and rapid identification of SARS-CoV-2 variants can potentially guide the treatment of COVID-19 patients and inform infection control and public health surveillance efforts. Here, we...
5.
Maruthamuthu S, Rajalingam K, Kaur N, Morvan M, Soto J, Lee N, et al.
Front Genet
. 2022 Mar;
13:845474.
PMID: 35273641
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection causes coronavirus disease-2019 (COVID-19) in some individuals, while the majority remain asymptomatic. Natural killer (NK) cells play an essential role in antiviral...
6.
Ng D, Granados A, Santos Y, Servellita V, Goldgof G, Meydan C, et al.
Sci Adv
. 2021 Feb;
7(6).
PMID: 33536218
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease-19 (COVID-19), has emerged as the cause of a global pandemic. We used RNA sequencing to analyze 286 nasopharyngeal (NP)...
7.
Gu W, Deng X, Lee M, Sucu Y, Arevalo S, Stryke D, et al.
Nat Med
. 2020 Nov;
27(1):115-124.
PMID: 33169017
We developed a metagenomic next-generation sequencing (mNGS) test using cell-free DNA from body fluids to identify pathogens. The performance of mNGS testing of 182 body fluids from 160 patients with ...
8.
Ng D, Goldgof G, Shy B, Levine A, Balcerek J, Bapat S, et al.
Nat Commun
. 2020 Sep;
11(1):4698.
PMID: 32943630
Given the limited availability of serological testing to date, the seroprevalence of SARS-CoV-2-specific antibodies in different populations has remained unclear. Here, we report very low SARS-CoV-2 seroprevalence in two San...
9.
Gu W, Reyes K, Hsu E, Miller S, Chiu C
medRxiv
. 2020 Jun;
PMID: 32511617
Real-time dissemination of epidemiological survey data from positive COVID-19 cases is critical to support efforts to contain or reduce spread of viral infection in the community. Here we detected a...
10.
Ng D, Goldgof G, Shy B, Levine A, Balcerek J, Bapat S, et al.
medRxiv
. 2020 Jun;
PMID: 32511477
We report very low SARS-CoV-2 seroprevalence in two San Francisco Bay Area populations. Seropositivity was 0.26% in 387 hospitalized patients admitted for non-respiratory indications and 0.1% in 1,000 blood donors....